In vitro pharmacological inhibition of KDM1A activity or siRNA knockdown of its expression significantly suppressed proliferation and invasion and induced apoptosis in colon cancer cells, suggesting that targeted inhibition of KDM1A may provide a new direction for the treatment of colon cancer [85]. This evidence concerns the gene KDM1A and colonic neoplasm.